Learning Objectives:
At the conclusion of this session, participants will be able to:
- discuss practical approaches to common questions and problems encountered in day-to-day practice of Transplant Infectious Diseases
- describe the level of evidence and consequences of diverse system-wide practices regarding prevention and treatment of selected infectious diseases of particular impact to transplant and oncology recipients
- identify sources for answers to uncommon questions regarding diagnosis, treatment and prevention of infectious diseases in transplant and oncology questions
Please email your questions before the session to Session.Questions@idsociety.org, Dr. Francisco Marty (fmarty@bwh.harvard.edu), or Dr. Raymund Razonable (Razonable.Raymund@mayo.edu).
Session.Questions@idsociety.org
Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Members-in-training, Microbiologists, Nurses, Pharmacists
Tracks: Adult ID, Epidemiology and Infection Control, Global ID
Moderator:
Francisco M. Marty, MD, FIDSA, Brigham and Women's Hospital
Presentations:
CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credits: ACPE 1.25 knowledge-based contact hours 0.125 of pharmacy CE
ACPE Number: 0221-9999-16-249-L04-P
Disclosures:
F. M. Marty,
Alexion:
Scientific Advisor
,
Consulting fee
Ansun:
Investigator
,
Research support
Astellas:
Consultant
and
Investigator
,
Consulting fee
and
Research support
Basilea:
Conference speaker
,
Speaker honorarium
Chimerix:
Consultant
and
Investigator
,
Consulting fee
and
Research support
Gilead:
Consultant
and
Investigator
,
Consulting fee
and
Research support
GlaxoSmithKline:
Consultant
and
Investigator
,
Consulting fee
and
Research grant
LFB, S.A.:
Consultant
,
Consulting fee
Merck:
Consultant
and
Investigator
,
Consulting fee
and
Research support
Shire:
Consultant
and
Investigator
,
Consulting fee
and
Research support
WHISCON:
Investigator
,
Research support
Pfizer:
Course speaker
,
Speaker honorarium
Fate Therapeutics:
Scientific Advisor
,
Consulting fee